Law, Politics, and Expert Panels at the US Food and Drug Administration
This Viewpoint discusses the lawfulness and credibility of the US Food and Drug Administration’s recent move to using expert panels rather than advisory committees for decision-making.
Authors
- Aaron S. Kesselheim
- C. Joseph Ross Daval
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.6812
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 41.85